COVID-19 (omicron JN.1) vaccine is under clinical development by Moderna and currently in Pre-Registration for Coronavirus Disease 2019 (COVID-19).

Stock-plunging mRNA vaccine maker, already in bed with feds on vaccine royalties, says booster not "causally" related without ...

Elasomeran + imelasomeran is under clinical development by Moderna and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

The Public Health Agency of Canada says federal funding for COVID-19 vaccines will stop this year and the provinces and ...

Five years ago, a cluster of people in Wuhan, China, fell sick with a virus never before seen in the world. The germ didn’t ...

The most recent mRNA vaccines, manufactured by Pfizer-BioNTech and Moderna, target the KP.2 Omicron subvariant. Novavax's updated protein-based vaccine targets the JN.1 subvariant of Omicron ...

Five years after the COVID-19 pandemic hit South Carolina and the U.S., it is still changing health care, from wastewater ...

Less than a year after China identified the virus, health authorities in the U.S. and Britain cleared vaccines made by Pfizer ...

COVID-19 has continued to claim lives at an average rate of about 900 deaths per week in the U.S. over the past year.

The omicron relative now dominant in the U.S. is ... health authorities in the U.S. and Britain cleared vaccines made by Pfizer and Moderna. Years of earlier research — including Nobel-winning ...